Press Releases Theraclion

Equities

ALTHE

FR0010120402

Market Closed - Euronext Paris Other stock markets 15:33:44 01/07/2024 BST			5-day change	1st Jan Change
0.365 ^EUR	+2.82%		+9.28%	-5.93%

06-24	Sonovein FDA Pivotal Study Treatments Completed: Theraclion Reaches Key Milestone on Schedule	CI
06-07	Theraclion: scientific publication hailed by stock market	CF

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

SONOVEIN® FDA Pivotal Study Treatments Completed: Theraclion Reaches Key Milestone on Schedule	06-24	BU
Theraclion : AGM 2024 Présentation	06-20	PU
Theraclion: SONOVEIN® Highlighted in Top Medical Conferences and Scientific Journal	06-06	BU
Theraclion Announces 2023 Financial Results and Continues Its Roadmap	03-27	BU
Theraclion : announces 2023 financial results and continues its roadmap	03-27	PU
Theraclion : Présentation AGM – 29 juin 2023	12-20	PU
Theraclion : Presentation AGM 29 juin 2023	24/07/23	PU
THERACLION : ANNOUNCES 2022 FINANCIAL RESULTS AND INFORMS ON THE COMPANY’S SHORT-TERM FINANCING	28/04/23	PU
THERACLION : SUCESSFULLY REPRESENTATED AT THE 8TH INTERNATIONAL SYMPOSIUM ON FOCUSED ULTRASOUND	14/11/22	PU
Theraclion : Last patient of first SONOVEIN® US study has been treated	17/10/22	PU
Theraclion : AGM 2022 Présentation	30/06/22	PU
Theraclion : Inside Information / Other news releases	24/01/22	PU
Theraclion : is deploying its scalable robotic platform SONOVEIN® in Europe	14/12/21	PU
Theraclion : results show strong recovery, allowing ambitious plans	23/09/21	PU
Theraclion : FDA approves the 1st trial with Theraclion’s vein therapy in the US	20/09/21	PU
Theraclion : Bernard Sabrier and Unigestion pass the 20% threshold, proof of confidence in the company’s development	10/06/21	PU
Theraclion : UVA Cancer Center to expand use of Theraclion’s HIFU system in cancer treatment research.	02/06/21	PU
Theraclion : In 2020, Theraclion has succeeded a crucial step for its technology.	22/03/21	PU
In 2020, Theraclion Has Succeeded a Crucial Step for Its Technology: Results Allow Further Expansion for the Next Two Years	22/03/21	BU
Theraclion : Strategy Is in Place for 2021 Despite the Impact of Covid-19 on Sales Revenues For 2020	19/01/21	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Theraclion

Equities

ALTHE

FR0010120402

Press Releases

Filters